Learning outcomes
By the end of this lesson you should be able to: describe the eight human herpesviruses, their primary disease, their site of latency and their reactivation; explain the clinical distinction between primary simplex infection and recurrent herpes labialis, and how acyclovir works; describe varicella–zoster, its dermatomal reactivation and the two vaccines against it; describe the poxviruses, smallpox eradication, and molluscum contagiosum; describe adenoviruses and their role in epidemic keratoconjunctivitis and pharyngitis; describe human papillomavirus and the E6–p53 and E7–pRb mechanism of oncogenesis; describe polyomaviruses, parvovirus B19 and hepatitis B, including the serological markers that define its life cycle.
Prerequisites
Lesson 10 — General virology. The Baltimore classification and the notion of latency established there are used throughout; lesson 2 for culture-based diagnosis.
The big idea
The DNA viruses are the master class of latency, and that fact shapes all eight herpesvirus diseases. Primary infection often passes unnoticed; the genome then persists for life in neurons or lymphocytes in a latent state; and immunosuppression, fever, ultraviolet light or stress reactivates it into a productive infection. The recurrent cold sore is not a reinfection — it is the same virus, dormant in the trigeminal ganglion, travelling down the nerve to the lip.
Latency carries a second consequence: because the virus persists for life in the host, a person with long-past infection still carries it, so infectious mononucleosis is diagnosed by a serological pattern, and an immunosuppressed transplant patient must be watched for cytomegalovirus reactivation long after the original infection.
Herpesviridae: the eight human herpesviruses
| Virus | Subfamily | Primary disease | Site of latency | Reactivation and salient facts |
|---|---|---|---|---|
| Herpes simplex virus 1 (HSV-1) | Alpha | Gingivostomatitis, keratitis, encephalitis in children and young adults | Sensory and autonomic nerve ganglia — the trigeminal ganglion | Recurrent herpes labialis; the most common sporadic encephalitis, with a predilection for the temporal lobe |
| Herpes simplex virus 2 (HSV-2) | Alpha | Genital herpes, neonatal herpes acquired in the birth canal | Sacral nerve root ganglia | Recurrent genital ulceration; a leading cause of neonatal encephalitis, and the reason for acute caesarean section with active lesions |
| Varicella–zoster virus (VZV, HHV-3) | Alpha | Chickenpox (varicella) — a generalised vesicular rash after respiratory transmission | Dorsal root ganglion of a single dermatome | Herpes zoster: painful vesicles confined to one dermatome, from reactivation in the dorsal root ganglion |
| Epstein–Barr virus (EBV, HHV-4) | Gamma | Infectious mononucleosis, and Burkitt lymphoma in African children | B lymphocytes | Reactivates in immunosuppression; causes nasopharyngeal carcinoma, post-transplant lymphoproliferative disease and oral hairy leukoplakia |
| Cytomegalovirus (CMV, HHV-5) | Beta | Infectious mononucleosis with a negative heterophile test | Monocytes and macrophages | The major opportunistic virus of transplant and AIDS; congenital CMV causes sensorineural deafness and microcephaly; ganciclovir is the drug of choice |
| Human herpesvirus 6 (HHV-6) | Beta | Roseola infantum (exanthem subitum) — the commonest cause of fever and rash in infants | T lymphocytes and monocytes | Febrile convulsions in infancy, and reactivation encephalitis after transplant |
| Human herpesvirus 7 (HHV-7) | Beta | Roseola-like illness in some children | T lymphocytes | Similar in kind, usually milder; diagnosed by PCR |
| Human herpesvirus 8 (HHV-8) | Gamma | Kaposi sarcoma, primary effusion lymphoma, Castleman disease | B lymphocytes and endothelial cells | The cause of Kaposi sarcoma in HIV, treated with highly active antiretroviral therapy plus chemotherapy |
NoteHeterophile antibody testing is the classical way to separate the two causes of mononucleosis. The Paul–Bunnell test detects a sheep-cell-agglutinin antibody produced by polyclonal B-cell activation by EBV, and the Monospot is its rapid form. CMV mononucleosis has an identical clinical picture but a negative heterophile test, which is the first clue to the correct diagnosis.
That selectivity is the clinical answer to 'why is acyclovir so safe?'. It does nothing in an uninfected cell because there is no viral thymidine kinase to activate it, and it stops the herpesvirus polymerase that it targets. The consequence of the same mechanism is resistance: acyclovir-resistant HSV, seen in immunocompromised patients with persistent ulcers, usually carries a mutation in the thymidine kinase gene, and is treated with foscarnet, which acts directly on the polymerase without needing activation.
Varicella–zoster
Varicella is a respiratory acquisition that disseminates, and is one of the most contagious human infections: the secondary attack rate in a susceptible household is about 90 per cent. It causes crops of vesicles at successive stages in different areas of the body — the rash is pleomorphic because each crop is a day later than the last. In the immunocompromised it produces progressive varicella with pneumonia, encephalitis and hepatitis; in pregnancy it causes congenital varicella syndrome.
Reactivation gives herpes zoster: a painful vesicular eruption in a single sensory dermatome, because the virus travels down the nerve from the dorsal root ganglion where it was silent. It is a disease of advancing age and cell-mediated immunosuppression, and its treatment is acyclovir or valacyclovir started within 72 hours, with amitriptyline and gabapentin for the post-herpetic neuralgia that follows.
| Vaccine | Type | Dose | Purpose |
|---|---|---|---|
| Varicella vaccine | Live attenuated Oka strain | Two doses | Prevent chickenpox in children and in seronegative adults |
| Zoster vaccine | Recombinant glycoprotein E with adjuvant, or a high-titre live vaccine | Two doses (recombinant) | Prevent shingles and post-herpetic neuralgia in older adults by boosting cell-mediated immunity |
Poxviridae
Poxviruses are the largest and most complex viruses: a brick or ovoid shape with a biconcave core, a lateral body, and a lipoprotein envelope, carrying a genome of 130–375 kilobase pairs of double-stranded DNA and encoding its own transcription machinery. Their replication in the cytoplasm is unique among DNA viruses, and is the reason they do not need the host nucleus at all.
| Virus | Disease | Key facts |
|---|---|---|
| Variola (smallpox) | A systemic febrile illness with a centrifugal vesicular rash that becomes pustular and scarring | Eradicated in 1980 by a global vaccination campaign — the only human disease ever eliminated; declared eradicated after a global verification by the World Health Organization |
| Vaccinia | The vaccine virus used against smallpox, a laboratory-derived poxvirus of uncertain origin | Too dangerous for routine use now, but retained for research and biodefence |
| Molluscum contagiosum | Umbilicated pearly papules with large eosinophilic molluscum bodies in the cytoplasm | A common childhood and sexually transmitted skin infection; intracytoplasmic molluscum bodies are the diagnostic pathognomonic finding |
| Monkeypox (mpox) | A febrile vesicular disease acquired from animal contacts, with lymphadenopathy | Now a global outbreak threat, prevented by cross-protection from smallpox vaccination and treated with tecovirimat |
NoteThe epidemiology of smallpox eradication is a study in virus biology. No animal reservoir, a short and identifiable incubation, and a vaccine that produced a visible scar that could be checked at the door — ring vaccination of contacts then brought the last case in 1977 and global certification in 1980. Monkeypox, by contrast, has a rodent and primate reservoir, so it cannot be eradicated by vaccination alone.
Adenoviridae
Adenoviruses are non-enveloped, icosahedral, with a double-stranded DNA genome and a characteristic fibre protein that attaches to the cell surface. There are more than 50 serotypes and they cause disease mostly in children and in closed communities.
| Serotype | Disease | Epidemiological setting |
|---|---|---|
| 1, 2, 5 and 6 | Endemic respiratory infection and pharyngitis, most in young children | Households and nurseries year-round |
| 3, 4, 7 and 21 | Pharyngoconjunctival fever and acute respiratory disease | Swimming pools and military recruits — a classic 'closed community' outbreak |
| 8, 19, 37 and 53 | Epidemic keratoconjunctivitis | Ophthalmic clinics, from a contaminated tonometer |
| 40 and 41 | Gastroenteritis in young children | The second commonest viral cause of childhood gastroenteritis after rotavirus |
| Any serotype | Disseminated adenovirus pneumonia and hepatitis | Stem-cell transplant recipients and other severe immunosuppression |
NoteAdenovirus vectors are, paradoxically, most valuable for what they do not cause. Replication-deficient adenoviruses, and now their helpers, carry therapeutic genes into cells in gene therapy and were the delivery vehicle for several COVID-19 vaccines — because the adenovirus capsid enters target cells efficiently while allowing an inserted transgene to be expressed without replicating.
Human papillomavirus: the oncogenic DNA virus
| Type | Disease | Oncogenicity |
|---|---|---|
| HPV 16 and 18 | High-grade cervical intra-epithelial neoplasia and invasive carcinoma of the cervix, and an increasing fraction of oropharyngeal carcinoma | Cause about 70 per cent of cervical cancers; fully preventable by vaccination |
| HPV 6 and 11 | Condylomata acuminata (genital warts) and recurrent respiratory papillomatosis | Low risk — these are the types included for wart prevention |
| HPV 1, 2 and 4 | Plantar and palmar warts | No malignant potential |
| HPV 5 and 8 | Cutaneous squamous cell carcinoma in epidermodysplasia verruciformis | Rare, in the genetically predisposed |
The mechanism is a clean example of viral oncogenesis. E6 binds p53 and directs it to cellular ubiquitination and degradation, so a cell with DNA damage no longer arrests in G1 or undergoes apoptosis; E7 binds the retinoblastoma protein and releases the transcription factor E2F that it normally holds back, so the cell enters S phase without permission. The two together disable the two principal tumour suppressor pathways, which is why HPV-induced cancer takes years of persistent infection to develop, and why HPV vaccination before sexual debut is a primary prevention of cancer, not merely of warts.
NoteThe HPV vaccine is a virus-like particle vaccine: self-assembling L1 capsid protein with no DNA inside, produced in yeast. It therefore cannot replicate, cannot cause infection, and generates a high-titre neutralising antibody response that is more effective than the antibody response from natural infection. The nine-valent vaccine covers 6, 11, 16, 18 and five further oncogenic types.
Polyomaviridae, Parvoviridae and Hepadnaviridae
| Virus | Genome | Disease | Diagnosis |
|---|---|---|---|
| JC polyomavirus | Circular double-stranded DNA | Progressive multifocal leukoencephalopathy — demyelination in advanced HIV and in natalizumab-treated patients | PCR on cerebrospinal fluid, with a characteristic MRI and bilateral asymmetrical white-matter lesions |
| BK polyomavirus | Circular double-stranded DNA | Nephropathy in renal transplant recipients and haemorrhagic cystitis in stem-cell transplants | Plasma and urine PCR, with decoy cells in urine cytology |
| Parvovirus B19 | Small single-stranded DNA of about 5.6 kb | Slapped-cheek disease (erythema infectiosum), aplastic crisis in sickle cell disease, hydrops fetalis in pregnancy, arthropathy | Serology for IgM and IgG; viral PCR in a pregnant or immunosuppressed patient |
| Hepatitis B (Dane particle) | Partially double-stranded circular DNA, replicating through an RNA intermediate by reverse transcription | Acute hepatitis, chronic hepatitis, cirrhosis, hepatocellular carcinoma; a vaccine-preventable cause of all three | HBsAg is the infection marker, HBeAg is the replication marker, and anti-HBs is the protective antibody |
The hepatitis B serological profile is a compact test of everything you know about viral replication. HBsAg appears early and is the first marker of infection; HBeAg and high viral DNA mark high infectivity and replication; IgG anti-HBc appears later and persists for life; and the development of anti-HBs — with the loss of HBsAg — marks resolution and immunity. A vaccinated person has anti-HBs without anti-HBc, whereas a person who resolved natural infection has both, and that difference distinguishes immunised from naturally immune patients.
NoteThe hepatitis B vaccine is a classic biotechnological product: HBsAg is expressed in Saccharomyces cerevisiae, assembles into 22-nanometre particles, and carries no viral nucleic acid, so it cannot cause infection. Three doses protect, and the vaccine was the first vaccine shown to prevent a human cancer — hepatocellular carcinoma.
Common mistakes
Watch outTreating all herpesviruses as behaving the same way. They differ in latency site and in consequence: HSV and VZV hide in dorsal root ganglia and come back as skin lesions, CMV hides in monocytes and comes back as invasive disease in transplant, and EBV hides in B cells and comes back as a lymphoproliferative disorder.
Watch outThinking HPV only causes cervical cancer. HPV 16 is a major cause of oropharyngeal squamous cell carcinoma in sexually active men and women, and the incidence of that cancer now exceeds that of cervical cancer in some high-income countries — which is the reason for the extension of HPV vaccination to boys.
Watch outConfusing HBsAg and anti-HBs. HBsAg is the antigen, and its presence with no anti-HBs means active infection; anti-HBs is the antibody, and its presence with no HBsAg means immunity, whether from vaccination or from resolved infection — the difference being the presence of anti-HBc, which is present only after natural infection.
Check your understanding
A patient with advanced HIV develops painful vesicles in a single left thoracic dermatome. Explain the mechanism and the treatment.
How does acyclovir achieve selective toxicity, and how does acyclovir-resistant HSV usually arise?
A serology shows HBsAg negative, anti-HBc positive and anti-HBs positive. What is the interpretation?
Multiple choice
Which pairing of herpesvirus with its site of latency is correct?
Which statement about human papillomavirus is correct?
A child with sickle cell disease develops a sudden drop in haemoglobin after a febrile illness with a slapped-cheek rash. Which virus, and which mechanism?
Summary and next
The DNA viruses are latency specialists: eight herpesviruses hiding in neurons and lymphocytes, poxviruses replicating uniquely in the cytoplasm and being eradicated in the case of smallpox, adenoviruses causing respiratory and gastroenteric disease and serving as vectors, papillomaviruses driving cancer through E6 and E7 and preventable by virus-like particle vaccination, polyomaviruses causing leukoencephalopathy and nephropathy in the immunosuppressed, parvovirus B19 halting erythropoiesis, and hepatitis B — the only DNA virus replicating through reverse transcription, with a serological pattern that records its life cycle.
Next: RNA viruses. You will meet the segmented antigenically drifting orthomyxoviruses, the paramyxoviruses, the arboviruses and flaviviruses, the enteroviruses with their eradication programme, and HIV with its reverse transcription and its treatment targets.